CBIS Latest News

Display # 
Cannabis Science, Inc. Finds Large-Scale Manufacturing and Product Distribution Facility in California and Eyes Nevada Property as Nevada Governor Issues Statement of Emergency Due to Potential Shortage of Cannabis 17 Jul 2017
Cannabis Science Steps Up the Fight Against Opioid Drug Addictions with its Initial Test Batch of Transdermal Patches and Unisex Rectal Suppositories Available Now in Los Angeles Dispensaries, Meeting a Growing Demand from Self-Medicating Patients 07 Jul 2017
Cannabis Science Releases its 2017 Guidance Report for 2nd Quarter 2017, and Outlines Company's Performance and Growth Opportunities as the Medical Cannabis Industry Expands Dramatically 05 Jul 2017
Cannabis Science Calls on All MMJ Companies to Recognize and Join the Fight Against Opioid Addiction and Deaths by Supporting Self-Medicating Patients to fight Opioid Abuse by Using all Forms of Ingested MMJ as a Viable Gateway out of Extreme Opioid Usage 28 Jun 2017
Cannabis Science Invests in the Research and Development of Cannabinoid-based Medications to Treat COPD and Asthma 23 Jun 2017
UPDATE - Cannabis Science Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expand its California Dispensary Network 22 Jun 2017
Cannabis Science, Inc. Receives U.S. Federal Government Clearance to Receive U.S. Federal Government Contracts 26 May 2017
Cannabis Science Releases First Test Batch of Suppositories to Aid Self-Medicating Patients That Require Alternative Delivery Methods With Severe Pain and Symptoms Related to Cancers, Anxiety, and Insomnia 11 May 2017
Cannabis Science Senior Executives Chair Special Sessions and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School 02 May 2017
Cannabis Science Senior Executives Arrive at the Global Health Catalyst Summit at Harvard Medical School 29 Apr 2017